Learn More
How do the risks and benefits of nanotechnology, as viewed by the public, compare with those associated with other technologies such as genetically modified organisms, stem cells, biotechnology and nuclear power? And when deciding to use a specific nanotechnology product, will consumers consider the risks, the benefits, or both? We report the first(More)
In 2003, under the auspices of the main UK funders of biological and biomedical research, a working group was established with a remit to review potential welfare issues for genetically altered (GA) mice, to summarize current practice, and to recommend contemporary best practice for welfare assessments. The working group has produced a report which makes(More)
Ultrasound in medical education has seen a tremendous growth over the last 10–20 years but ultrasound technology has been around for hundreds of years and sound has an even longer scientific history. The development of using sound and ultrasound to understand our body and our surroundings has been a rich part of human history. From the development of(More)
PRESIDENT OBAMA’S EARLY STRONG STATEMENTS ABOUT SCIENCE, UNDERSCORED BY THE outstanding team of scientific experts he has assembled and big bucks in the stimulus package, have been a breath of fresh air. Understandably, there is some temptation to rest easy and not worry about happenings in Washington, comforted by the thought that U.S. science and science(More)
SIR — David Goldston appropriately demolishes the idea of a US presidential candidate debate on science, in his Column ‘A debatable proposition’ (Nature 451, 621; 2008). It’s hard to imagine anything worse for the cause of science than to subject it to the sort of high-profile demagogic posturing now reserved for immigration, medical care, social security,(More)
A s President Trump takes office, he has the enormous undertaking of making thousands of political appointments across the federal government, including nearly 800 nominations requiring Senate confirmation. Among his top priorities should be to nominate a science adviser and to staff the Office of Science and Technology Policy (OSTP), the single agency in(More)
T here is a growing and troubling assault on using credible scientific knowledge in U.S. government regulation that will put science and democracy at risk if unchecked. We present five examples, and the false premises on which they are based, of current attempts in the U.S. Congress in the supposed pursuit of transparency and accountability but at the(More)